Zhejiang Sunflower Great Health Co., Ltd. (SHE:300111)
China · Delayed Price · Currency is CNY 3.200
-0.160 (-4.76%)
Nov 13, 2026, 3:04 PM CST
SHE:300111 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 242.14 | 270.16 | 329.2 | 334.96 | 332.63 | 295.56 |
Other Revenue | 1.38 | 1.38 | 1.17 | 3.46 | 3.23 | 1.73 |
| 243.52 | 271.53 | 330.37 | 338.42 | 335.86 | 297.29 | |
Revenue Growth | -19.61% | -17.81% | -2.38% | 0.76% | 12.97% | 3.60% |
Cost of Revenue | 194.76 | 217.41 | 256.14 | 254.82 | 239.68 | 188.39 |
Gross Profit | 48.76 | 54.13 | 74.23 | 83.6 | 96.17 | 108.9 |
Selling, General & Admin | 48.07 | 51.81 | 60.84 | 86.87 | 83.95 | 83.48 |
Research & Development | 9.16 | 10.83 | 19.09 | 19.11 | 14.19 | 12.27 |
Other Operating Expenses | 1.88 | 2.58 | 2.37 | 2.44 | 1.02 | 2.24 |
Operating Expenses | 67.38 | 65.78 | 82.32 | 70.81 | 99.02 | 59.45 |
Operating Income | -18.62 | -11.65 | -8.09 | 12.79 | -2.84 | 49.45 |
Interest Expense | -0.04 | -0.01 | -1.74 | -4.56 | -0.44 | -0.06 |
Interest & Investment Income | 9.02 | 11.43 | 17.84 | 15.11 | 7.5 | 6.41 |
Currency Exchange Gain (Loss) | 0.51 | 0.51 | 1.94 | 1.47 | 1.23 | -0.21 |
Other Non Operating Income (Expenses) | -1.83 | -0.21 | -0.16 | -0.1 | -0.58 | -0.28 |
EBT Excluding Unusual Items | -10.96 | 0.07 | 9.78 | 24.71 | 4.87 | 55.32 |
Gain (Loss) on Sale of Investments | 0.12 | - | - | - | - | - |
Gain (Loss) on Sale of Assets | -2.2 | -1.75 | - | - | -0 | -4.56 |
Asset Writedown | -5.27 | -6.14 | -0.19 | -0.12 | -0.07 | -0.1 |
Legal Settlements | - | - | - | - | - | -0.04 |
Other Unusual Items | -2.69 | 2.44 | 2.98 | 0.31 | -0.17 | 18.69 |
Pretax Income | -20.99 | -5.37 | 12.58 | 24.9 | 4.63 | 69.31 |
Income Tax Expense | -0.81 | -1.38 | -0.78 | 0.99 | 0.07 | 3.44 |
Earnings From Continuing Operations | -20.18 | -3.99 | 13.36 | 23.91 | 4.56 | 65.87 |
Minority Interest in Earnings | -1.14 | -0.39 | -5.53 | -2.16 | -5.69 | -12.46 |
Net Income | -21.32 | -4.38 | 7.83 | 21.75 | -1.14 | 53.42 |
Net Income to Common | -21.32 | -4.38 | 7.83 | 21.75 | -1.14 | 53.42 |
Net Income Growth | - | - | -64.01% | - | - | -4.39% |
Shares Outstanding (Basic) | 1,287 | 1,287 | 1,305 | 1,279 | 1,139 | 1,113 |
Shares Outstanding (Diluted) | 1,287 | 1,287 | 1,305 | 1,279 | 1,139 | 1,113 |
Shares Change | 3.83% | -1.33% | 1.97% | 12.35% | 2.32% | -0.62% |
EPS (Basic) | -0.02 | 0.00 | 0.01 | 0.02 | -0.00 | 0.05 |
EPS (Diluted) | -0.02 | 0.00 | 0.01 | 0.02 | -0.00 | 0.05 |
EPS Growth | - | -50.00% | -64.71% | - | - | -3.79% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | -37.68 | -5.56 | 18.55 | -7.43 | -17.99 | 82.38 |
Free Cash Flow Per Share | -0.03 | -0.00 | 0.01 | -0.01 | -0.02 | 0.07 |
Gross Margin | 20.02% | 19.93% | 22.47% | 24.70% | 28.63% | 36.63% |
Operating Margin | -7.65% | -4.29% | -2.45% | 3.78% | -0.85% | 16.63% |
Profit Margin | -8.75% | -1.62% | 2.37% | 6.43% | -0.34% | 17.97% |
Free Cash Flow Margin | -15.47% | -2.05% | 5.61% | -2.19% | -5.36% | 27.71% |
EBITDA | -4.45 | 3.63 | 8.68 | 29.84 | 12.81 | 68.55 |
EBITDA Margin | -1.83% | 1.34% | 2.63% | 8.82% | 3.81% | 23.06% |
D&A For EBITDA | 14.18 | 15.29 | 16.77 | 17.05 | 15.65 | 19.1 |
EBIT | -18.62 | -11.65 | -8.09 | 12.79 | -2.84 | 49.45 |
EBIT Margin | -7.65% | -4.29% | -2.45% | 3.78% | -0.85% | 16.63% |
Effective Tax Rate | - | - | - | 3.98% | 1.54% | 4.96% |
Revenue as Reported | 243.52 | 271.53 | 330.37 | 338.42 | 335.86 | 297.29 |